FIGURE 1.
Pemetrexed (PEM) decreases the viability of non–small‐cell lung cancer (NSCLC) cells. Cancer cells were cultured in the presence of the indicated doses of PEM for 2 d. The percent cell viability was determined by WST8 assay. **P < 0.01
Pemetrexed (PEM) decreases the viability of non–small‐cell lung cancer (NSCLC) cells. Cancer cells were cultured in the presence of the indicated doses of PEM for 2 d. The percent cell viability was determined by WST8 assay. **P < 0.01